Global Antiviral Drugs Market Report By Mechanism Of Action (Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, And Others), Type (Generic And Branded), Application (HIV, Hepatitis, Herpes Simplex Virus, Influenza, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11211443
January 2020
Report Formats:

As per this study the Global Antiviral Drugs Market was valued USD XXX MN (by revenue) in 2019 and is anticipated to reach USD XXX MN by 2026 with a CAGR of X.X%.
 
Antiviral drugs are the one which specifically is used to treat viral infectious disease. Unlike antibiotic, antiviral do not kill the target pathogen rather they stop the development of the pathogen. Even there are few listed natural antiviral which is produced by plants, eucalyptus is one of those. Researchers are working on extending the range of antiviral drugs to meet the growing need of the product owing to the rising incidence of viral diseases around the world.
 
Market Dynamics
 
The market of antiviral drugs is growing mainly on the ground of rising prevalence of infectious disease along with the presence of strong pipeline of the product. The rise in competition among the manufacturer for the development of novel drugs is also likely to enhance the market of the antiviral drugs. Also, increasing STD's disease and growing awareness among the people for early and efficient treatment is also projected to raise the demand for the product along with the increasing healthcare expenditure, will boost the growth of the market. However, the high cost of the drugs is likely to restrain the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of antiviral drugs.
 
Market Segmentation
 
The broad antiviral drugs market has been sub-grouped into mechanism of action, type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Mechanism of Action

  • Nucleotide Polymerase Inhibitors
  • Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • Others
 
By Type
  • Generic
  • Branded
 
By Application
  • HIV
  • Hepatitis
  • Herpes Simplex Virus
  • Influenza
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for antiviral drugs in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Antiviral Drugs Market By Revenue (USD MN)

Europe Antiviral Drugs Market By Revenue

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the antiviral drugs market includes  AbbVie, Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy’s Laboratories Ltd, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche AG, Johnson and Johnson, Merck & Co, and Mylan N.V.. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Antiviral Drugs Market
       2.2. Global Antiviral Drugs Market Snapshot
 
3 . ANTIVIRAL DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Antiviral Drugs Market
       3.3. Market Restraints of Antiviral Drugs Market
       3.4. Opportunities of Antiviral Drugs Market
       3.5. Trends of Antiviral Drugs Market
       3.6. Porter’s Five Force Analysis of Antiviral Drugs Market
       3.7. Antiviral Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Mechanism of Action
           3.7.2 Market Attractive Analysis by Type
           3.7.3 Market Attractive Analysis by Application
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Antiviral Drugs Value Chain Analysis
       4.2. Antiviral Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Antiviral Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Antiviral Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL ANTIVIRAL DRUGS MARKET ANALYSIS BY MECHANISM OF ACTION
       5.1 Overview by Mechanism of Action
       5.2 Global Antiviral Drugs Market Analysis by Mechanism of Action
       5.3 Market Analysis of Nucleotide Polymerase Inhibitors by Regions
       5.4 Market Analysis of Reverse Transcriptase Inhibitors by Regions
       5.5 Market Analysis of Protease Inhibitors by Regions
       5.6 Market Analysis of Others by Regions
 
6 . GLOBAL ANTIVIRAL DRUGS MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Global Antiviral Drugs Market Analysis by Type
       6.3 Market Analysis of Generic by Regions
       6.4 Market Analysis of Branded by Regions
 
7 . GLOBAL ANTIVIRAL DRUGS MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Global Antiviral Drugs Market Analysis by Application
       7.3 Market Analysis of HIV by Regions
       7.4 Market Analysis of Hepatitis by Regions
       7.5 Market Analysis of Herpes Simplex Virus by Regions
       7.6 Market Analysis of Influenza by Regions
       7.7 Market Analysis of Others by Regions
 
8 . GLOBAL ANTIVIRAL DRUGS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Antiviral Drugs Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Antiviral Drugs Market Estimate by Market Segment
           8.4.3. Europe Antiviral Drugs Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Antiviral Drugs Market Estimate by Market Segment
           8.5.3. Asia Pacific Antiviral Drugs Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Antiviral Drugs Market Estimate by Market Segment
           8.6.3. Latin America Antiviral Drugs Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Antiviral Drugs Market Estimate by Market Segment
           8.7.3. Middle East & Africa Antiviral Drugs Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE ANTIVIRAL DRUGS COMPANIES
       9.1. Antiviral Drugs Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF ANTIVIRAL DRUGS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. AbbVie
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Aurobindo Pharma
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Bristol-Myers-Squibb
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Cipla
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Dr. Reddy’s Laboratories Ltd.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Gilead Sciences
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. GlaxoSmithKline
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Hoffmann-La Roche AG
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Johnson and Johnson
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Merck & Co
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Mylan N.V.
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Antiviral Drugs Market Snapshot
  • Drivers of The Global Antiviral Drugs Market Impact Analysis
  • Restraints of The Global Antiviral Drugs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Global Antiviral Drugs Market Analysis in Nucleotide Polymerase Inhibitors by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Reverse Transcriptase Inhibitors by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Protease Inhibitors by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Others by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis by Type (USD MN)
  • Global Antiviral Drugs Market Analysis in Generic by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Branded by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis by Application (USD MN)
  • Global Antiviral Drugs Market Analysis in HIV by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Hepatitis by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Herpes Simplex Virus by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Influenza by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Others by Geography (USD MN)
  • Global Antiviral Drugs Market by Geography (USD MN)
  • North America Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • North America Antiviral Drugs Market Estimate by Type (USD MN)
  • North America Antiviral Drugs Market Estimate by Application (USD MN)
  • North America Antiviral Drugs Market Estimate by Country (USD MN)
  • United State Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • United State Antiviral Drugs Market Estimate by Type (USD MN)
  • United State Antiviral Drugs Market Analysis by Application (USD MN)
  • Rest of North America Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Rest of North America Antiviral Drugs Market Estimate by Type (USD MN)
  • Rest of North America Antiviral Drugs Market Estimate by Application(USD MN)
  • Europe Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Europe Antiviral Drugs Market Estimate by Type (USD MN)
  • Europe Antiviral Drugs Market Estimate by Application (USD MN)
  • United Kingdom Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • United Kingdom Antiviral Drugs Market Estimate by Type (USD MN)
  • United Kingdom Antiviral Drugs Market Estimate by Application (USD MN)
  • France Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • France Antiviral Drugs Market Estimate by Type (USD MN)
  • France Antiviral Drugs Market Estimate by Application (USD MN)
  • Germany Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Germany Antiviral Drugs Market Estimate by Type (USD MN)
  • Germany Antiviral Drugs Market Estimate by Application (USD MN)
  • Rest of Europe Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Rest of Europe Antiviral Drugs Market Estimate by Type (USD MN)
  • Rest of Europe Antiviral Drugs Market Estimate by Application (USD MN)
  • Asia Pacific Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Asia Pacific Antiviral Drugs Market Estimate by Type (USD MN)
  • Asia Pacific Antiviral Drugs Market Estimate by Application (USD MN)
  • Asia Pacific Antiviral Drugs Market Estimate by Country (USD MN)
  • China Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • China Antiviral Drugs Market Estimate by Type (USD MN)
  • China Antiviral Drugs Market Estimate by Application (USD MN)
  • Japan Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Japan Antiviral Drugs Market Estimate by Type (USD MN)
  • Japan Antiviral Drugs Market Estimate by Application (USD MN)
  • India Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • India Antiviral Drugs Market Estimate by Type (USD MN)
  • India Antiviral Drugs Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Rest of Asia Pacific Antiviral Drugs Market Estimate by Type (USD MN)
  • Rest of Asia Pacific Antiviral Drugs Market Estimate by Application (USD MN)
  • Latin America Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Latin America Antiviral Drugs Market Estimate by Type (USD MN)
  • Latin America Antiviral Drugs Market Estimate by Application (USD MN)
  • Latin America Antiviral Drugs Market Estimate by Country (USD MN)
  • Brazil Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Brazil Antiviral Drugs Market Estimate by Type (USD MN)
  • Brazil Antiviral Drugs Market Estimate by Application (USD MN)
  • Rest of Latin America Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Rest of Latin America Antiviral Drugs Market Estimate by Type (USD MN)
  • Rest of Latin America Antiviral Drugs Market Estimate by Application (USD MN)
  • Middle East & Africa Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Middle East & Africa Antiviral Drugs Market Estimate by Type (USD MN)
  • Middle East & Africa Antiviral Drugs Market Estimate by Application (USD MN)
  • Middle East & Africa Antiviral Drugs Market Estimate by Country (USD MN)
  • Middle East Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Middle East Antiviral Drugs Market Estimate by Type (USD MN)
  • Middle East Antiviral Drugs Market Estimate by Application (USD MN)
  • Africa Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Africa Antiviral Drugs Market Estimate by Type (USD MN)
  • Africa Antiviral Drugs Market Estimate by Application (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Antiviral Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Antiviral Drugs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Mechanism of Action
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Antiviral Drugs Market Analysis by Mechanism of Action (USD MN)
  • Global Antiviral Drugs Market Analysis in Nucleotide Polymerase Inhibitors by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Reverse Transcriptase Inhibitors by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Protease Inhibitors by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Others by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis by Type (USD MN)
  • Global Antiviral Drugs Market Analysis in Generic by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Branded by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis by Application (USD MN)
  • Global Antiviral Drugs Market Analysis in HIV by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Hepatitis by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Herpes Simplex Virus by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Influenza by Geography (USD MN)
  • Global Antiviral Drugs Market Analysis in Others by Geography (USD MN)
  • Latin America Antiviral Drugs Market by Revenue
  • Middle East & Africa Antiviral Drugs Market by Revenue
  • Recent Development in Antiviral Drugs Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials